No Data
No Data
Alibaba Health Information Technology (OTC:ALBHF) Trading Up 0.9%
Alibaba Health Information Technology Limited (OTC:ALBHF – Get Rating) shares were up 0.9% during trading on Monday . The company traded as high as $0.72 and last traded at $0.72. Approximately 120 sh
Alibaba Health Information Technology (OTC:ALBHF) Shares Down 1%
Alibaba Health Information Technology Limited (OTC:ALBHF – Get Rating) shares dropped 1% during trading on Monday . The stock traded as low as $0.75 and last traded at $0.76. Approximately 4,750 share
Alibaba Health Information Technology (OTC:ALBHF) Trading Down 3.4%
Alibaba Health Information Technology Limited (OTC:ALBHF – Get Rating) shares fell 3.4% on Thursday . The stock traded as low as $0.90 and last traded at $0.90. 2,000 shares were traded during tradi
Alibaba Health Information Technology (OTC:ALBHF) Stock Price Down 2.2%
Alibaba Health Information Technology Limited (OTC:ALBHF – Get Rating) dropped 2.2% on Tuesday . The stock traded as low as $0.90 and last traded at $0.90. Approximately 5,010 shares changed hands du
Coca-Cola Company: people will pay attention to larger brands when they are prepared to deal with the limited impact of Delta variants on the market.
John Murphy, Coca-Cola Company's chief financial officer, said on Wednesday that the company would rely on its epidemic-tested strategy to focus on larger brands and increase investment in the supply chain to cope with the potential impact of novel coronavirus's Delta variant. The reopening of the global economy helped the beverage giant exceed expectations for the second quarter, raising its full-year guidance. Murphy said sales in some Asian markets were hit by the rebound in the epidemic in the second quarter. Some possible effects have also been added to the revised sales forecast. Murphy said: "when the market is subject to more restrictions
J.P. Morgan's investment banking division recorded the best performance in the second quarter thanks to hot mergers and acquisitions
J.P. Morgan's investment banking division set the best quarterly results, as the unprecedented performance of deal matching in the first half of the year boosted profits. However, the company's stock price fell, as expenses rose and loans were still far from growing. Fees for M&A advisors and stock and bond underwriting services soared 25% in the second quarter, breaking analysts' expectations and bringing net profit to $11.9 billion. However, non-interest expenses increased 4% year over year, which was also more than analysts' expectations. Furthermore, the bank said it plans to spend 1 billion more dollars than previously announced financial estimates. The stock price fell 1.2%. J.P. Morgan's results have kicked off the banking industry's earnings season. You can use it
No Data